Ildong Pharmaceutical Co., Ltd.

₩12,250As of Sun 8 Nov 2026, 12:00 UTC
KRX:249420Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (0.18%)
Div yield 1.63%
ROE 18.50%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.98
PE TTM 8.906
TSR TTM (47.53%)
Mkt cap ₩386.0B
ROIC 6.54%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩12,924
5.50%
(73.28%)
Buy 1|0|1|5|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
153.87
170.50
180.91
199.46
18.84%
21.68%
18.87%
32.01%
Revenue₩B
16.65
17.05
17.40
18.32
3.00%
5.07%
5.05%
9.47%
Peers (US$284.6M)
Cap (US$)
PE
239.8M
37.98x
Capital
TTM
5Y
10Y
Leveragex
0.601
0.338
0.362
EBIT/Intx
1.322
0.486
0.465
Own earn%
(298.67)
(4.53)
(47.62)
Sh yield%
35.99
39.93
39.97
Owners
Insiders/Inst%
12.55
22.17
Short interest%
3.69
SBC / revenue%
3.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
18–24
$1 testx
−0.3
Incr. ROIC%
5